Sepio Capital, LP Regeneron Pharmaceuticals, Inc. Transaction History

Sepio Capital, LP

$1.03 Billion
Q3 2024

A detailed history of Sepio Capital, LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sepio Capital, LP holds 2,551 shares of REGN stock, worth $1.93 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

2,551

Previous 2,570 0.74%

Holding current value

$1.93 Million

Previous $2.7 Million 0.74%

% of portfolio

0.26%

Previous 0.29%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $19,457 - $22,833	-19 Reduced 0.74%	2,551 $2.68 Million
Q2 2024 Aug 15, 2024	SELL	$883.2 - $1071.19 $16,780 - $20,352	-19 Reduced 0.73%	2,570 $2.7 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $102,003 - $112,248	-113 Reduced 4.18%	2,589 $2.49 Million
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $436,426 - $496,397	-563 Reduced 17.24%	2,702 $2.37 Million
Q3 2023 Nov 08, 2023	SELL	$692.45 - $844.37 $2.57 Million - $3.14 Million	-3,718 Reduced 53.24%	3,265 $2.69 Million
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $47,602 - $56,463	68 Added 0.98%	6,983 $5.02 Million
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $279,681 - $339,884	-411 Reduced 5.61%	6,915 $5.68 Million
Q4 2022 Feb 03, 2023	SELL	$705.89 - $766.39 $914,127 - $992,475	-1,295 Reduced 15.02%	7,326 $5.29 Million
Q3 2022 Oct 28, 2022	SELL	$573.97 - $724.32 $2.76 Million - $3.48 Million	-4,800 Reduced 35.76%	8,621 $5.94 Million
Q2 2022 Jul 26, 2022	BUY	$548.35 - $738.84 $3.04 Million - $4.09 Million	5,535 Added 70.19%	13,421 $7.93 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $499,305 - $585,982	-839 Reduced 9.62%	7,886 $5.51 Million
Q4 2021 Jan 25, 2022	SELL	$543.48 - $670.97 $22,826 - $28,180	-42 Reduced 0.48%	8,725 $5.51 Million
Q3 2021 Nov 03, 2021	SELL	$574.03 - $680.96 $2.05 Million - $2.43 Million	-3,566 Reduced 28.91%	8,767 $5.31 Million
Q2 2021 Jul 26, 2021	BUY	$472.8 - $558.54 $1.39 Million - $1.64 Million	2,933 Added 31.2%	12,333 $6.89 Million
Q1 2021 May 10, 2021	SELL	$446.73 - $548.2 $24,570 - $30,151	-55 Reduced 0.58%	9,400 $4.45 Million
Q4 2020 Feb 10, 2021	SELL	$478.3 - $607.98 $730,842 - $928,993	-1,528 Reduced 13.91%	9,455 $4.57 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $232,608 - $281,055	-427 Reduced 3.74%	10,983 $6.15 Million
Q2 2020 Aug 04, 2020	SELL	$493.32 - $643.92 $171,675 - $224,084	-348 Reduced 2.96%	11,410 $7.12 Million
Q1 2020 Apr 29, 2020	BUY	$336.18 - $494.43 $103,879 - $152,778	309 Added 2.7%	11,758 $5.75 Million
Q4 2019 Feb 06, 2020	SELL	$274.13 - $376.51 $305,929 - $420,185	-1,116 Reduced 8.88%	11,449 $4.3 Million
Q3 2019 Oct 25, 2019	BUY	$273.46 - $318.39 $514,104 - $598,573	1,880 Added 17.59%	12,565 $3.49 Million
Q2 2019 Aug 08, 2019	BUY	$299.6 - $414.82 $32,057 - $44,385	107 Added 1.01%	10,685 $3.34 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $606,118 - $716,059	-1,629 Reduced 13.34%	10,578 $4.34 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $4.1 Million - $4.92 Million	12,207 New	12,207 $4.56 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.

Account